Boston Scientific announced the FDA approval of expanded labeling for its pulsed field ablation system which now includes ...

The VARIPULSE™ Platform is the first Pulsed Field Ablation (PFA) system fully integrated with the CARTO™ 3 electroanatomical mapping system, designed to drive efficiency, reproducibility, and ...

Patients whose atrial fibrillation lasts longer than seven days and who do not respond well to drug therapy are now eligible ...

Marlborough: Boston Scientific Corporation has announced that the company has received approval from the U.S. Food and Drug ...

The US Food and Drug Administration (FDA) has approved Boston Scientific’s expanded instructions for use (IFU) labelling of ...

The benefit seems durable, but one expert says patients should be aware there’s “some risk of stroke” during the procedure.

Boston Scientific receives US FDA approval for expanded labelling of Farapulse PFA System: Marlborough, Massachusetts Tuesday, July 8, 2025, 11:00 Hrs [IST] Boston Scientific Corp ...

Boston Scientific secured FDA approval to expand its FARAPULSE system, strengthening its grip in atrial fibrillation ...

Kardium announced today that it raised $250 million in a new financing round to support the launch of its pulsed field ablation system. New investors, including Janus Henderson Investors, Qatar ...

St. Luke’s cardiac electrophysiology team is first in the Lehigh Valley and Northeastern Pennsylvania to offer pulsed field ablation, a new and improved treatment for atrial fibrillation. This common ...

Doha, Qatar: Qatar Investment Authority (QIA) has invested in innovative healthcare company, Kardium Inc., the developer of the Globe Pulsed Field System- an innovative treatment for atrial ...

For patients with atrial fibrillation, catheter ablation reduces the risks for ischemic stroke at more than 30 days, ...